Stay updated on Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial

Sign up to get notified when there's something new on the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The study record now indicates recruitment is closed (no longer looking for participants), and the history shows a new revision (v3.6.0) added with the previous revision (v3.5.5) removed.
    Difference
    0.3%
    Check dated 2026-06-12T23:44:00.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.5.5 to the history and removed Revision: v3.5.4 from the record.
    Difference
    0.1%
    Check dated 2026-06-05T17:13:18.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    A new history entry for revision v3.5.4 has been added to the Study Record Versions list, while v3.5.3 was removed, updating the sequence of record revisions.
    Difference
    0.1%
    Check dated 2026-05-15T06:00:25.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, reflecting a change to the site’s revision label without altering the underlying study record content.
    Difference
    0.1%
    Check dated 2026-04-24T05:48:18.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:17:34.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    - Revision history updated: v3.5.0 added; v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-18T22:51:16.000Z thumbnail image

Stay in the know with updates to Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page.